Vijaya Diagnostic Centre Limited has announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported total income of ₹23,951.22 lakhs and a profit after tax of ₹5,314.76 lakhs for the period. The Board of Directors also proposed a dividend of ₹2 per equity share for the financial year 2025-26, subject to member approval.
Vijaya Diagnostic Centre Announces Q1 FY27 Financial Results
Vijaya Diagnostic Centre Limited has officially released its unaudited standalone and consolidated financial results for the first quarter that concluded on June 30, 2026. The board of directors considered and approved these results during their meeting held on August 06, 2026.
Key Financial Highlights (Unaudited Standalone)
For the quarter ended June 30, 2026, the company reported a total income of ₹22,755.72 lakhs. The profit after tax for the same period stood at ₹5,314.76 lakhs. These figures reflect the company’s performance in the initial quarter of the fiscal year.
Consolidated Financial Performance
On a consolidated basis, Vijaya Diagnostic Centre Limited generated a total income of ₹23,951.22 lakhs for the quarter ended June 30, 2026. The profit after tax for the group during this period was ₹5,310.11 lakhs. The company operates in a single segment, “Diagnostic services,” with performance and resource allocation focused accordingly.
Dividend Proposal and Shareholder Information
In a significant decision for its shareholders, the Board of Directors has proposed and recommended a dividend of ₹2 per equity share of Re. 1 each (200%) for the financial year 2025-26. This proposal is contingent upon the approval of the members at the upcoming Annual General Meeting. The company also noted the granting of 179,500 employee stock options to eligible employees during the quarter.
Limited Review and Auditor’s Report
The financial results have undergone a limited review by the statutory auditors, BSR and Co, Chartered Accountants. Their report, dated August 06, 2026, provides an unmodified conclusion on the accompanying unaudited financial results, confirming compliance with the relevant accounting standards and regulations.
Amalgamation Details
The financial results also reflect the amalgamation of Medinova Millennium MRI Services LLP with the company, accounted for under the pooling of interest method. This event, approved by the National Company Law Tribunal (NCLT) on October 13, 2025, required restating comparative financial information.
Source: BSE
